Browse by author
Lookup NU author(s): Paddy Stevenson
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Anaemia is a common complication of cancer and cancer therapies, and fatigue is one of the most common symptoms of anaemia, disrupting functional performance and reducing overall quality of life. The positive effects of treating renal patients with recombinant human erythropoietin are well documented. This case report series details the specific effects of fatigue on individual patients with cancer and their way of life, and describes their significant improvement in lifestyle following the reversal of anaemia using recombinant human erythropoietin, epoetin alfa.
Author(s): Libretto SE, Barrett-Lee PJ, Gorst DW, Kaczmarski R, McAdam K, Stevenson P, Thomas R
Publication type: Article
Publication status: Published
Journal: European Journal of Cancer Care
ISSN (print): 0961-5423
ISSN (electronic): 1365-2354
Publisher: Wiley-Blackwell Publishing Ltd.
Altmetrics provided by Altmetric